MIT class project turns into an FDA-cleared treatment for tremors
Summary
MIT News reports Encora Therapeutics' wrist-worn device originated from MIT's 2.009 product-design class and has earned FDA 510(k) clearance to treat essential tremor. The piece traces the journey from a classroom prototype and clinical trials to regulatory approval and commercial expansion, highlighting patient benefits and a platform-technology potential for neuromodulation.